MOLECULAR MARKERS OF HEMOSTATIC PROCESSES - IMPLICATIONS IN DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF THROMBOTIC AND HEMORRHAGIC DISORDERS

被引：0
|
作者：
BICK, RL
FAREED, J
SQUILLACI, G
WALENGA, J
BERMES, EW
MESSMORE, HL
机构：
[1] LOYOLA UNIV,MED CTR,MAYWOOD,IL 60153
[2] SAN JOAQUIN HEMATOL & ONCOL GRP,BAKERSFIELD,CA 93305
来源：
FEDERATION PROCEEDINGS | 1983年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1031 / 1031
页数：1
相关论文
共 50 条
  • [41] The molecular rationale for steroid based therapy of leukemia: diagnostic and therapeutic implications
    Yefenof, E.
    Stepensky, P.
    Shlomit, K.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S179 - S180
  • [42] Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications
    Fulda, Simone
    Rajalingam, Krishnaraj
    Dikic, Ivan
    EMBO MOLECULAR MEDICINE, 2012, 4 (07) : 545 - 556
  • [43] The reporting of prostate cancer on needle biopsy: prognostic and therapeutic implications and the utility of diagnostic markers
    Zhou, M
    Epstein, JI
    PATHOLOGY, 2003, 35 (06) : 472 - 479
  • [44] Management Tools for Molecular Diagnostic Testing: Financial and Clinical Implications
    Moeller, Douglas
    AMERICAN HEALTH AND DRUG BENEFITS, 2009, 2 (06): : 291 - 292
  • [45] Role of molecular diagnostic markers in the management of indeterminate and suspicious thyroid nodules
    Najafian, Alireza
    Zeiger, Martha A.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2014, 1 (01) : 49 - 57
  • [46] New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications
    Luna, Daniel E.
    Shinohara, Michi M.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (03) : 83 - 88
  • [47] New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications
    Daniel E. Luna
    Michi M. Shinohara
    Current Hematologic Malignancy Reports, 2023, 18 : 83 - 88
  • [48] Good or poor responses of hemostatic molecular markers in patients with hematopoietic disorders after treatment of disseminated intravascular coagulation
    Watanabe, R
    Wada, H
    Yamamuro, M
    Inoue, A
    Watanabe, M
    Kumeda, K
    Sakakura, M
    Okugawa, Y
    Nakasaki, T
    Deguchi, H
    Gabazza, EC
    Mori, Y
    Nishikawa, M
    Nobori, T
    Shiku, H
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2003, 9 (01) : 71 - 77
  • [49] MOLECULAR DIAGNOSIS OF HEMORRHAGIC SEPTICAEMIA IN A MURRAH BUFFALO AND ITS THERAPEUTIC MANAGEMENT WITH CEFTIOFUR SODIUM
    Chethan, G. E.
    Vadhana, A. Prasanna
    De, U. K.
    Thakur, Neeraj
    Raguvaran, R.
    Gopalakrishnan, A.
    Akhilesh
    Krishna, S. Vamshi
    Dixit, S. K.
    BUFFALO BULLETIN, 2019, 38 (03): : 561 - 569
  • [50] Diagnostic and therapeutic management of carcinoma of unknown primary: histopathological and molecular diagnosis
    Viale, G.
    Mastropasqua, M. G.
    ANNALS OF ONCOLOGY, 2006, 17 : X163 - X167
12345